BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Brugaletta S, Martin-Yuste V, Ferreira-González I, Cola C, Alvarez-Contreras L, Antonio MD, Garcia-Moll X, García-Picart J, Martí V, Balcells-Iranzo J, Sabaté M. Adequate antiplatelet regimen in patients on chronic anti-vitamin K treatment undergoing percutaneous coronary intervention. World J Cardiol 2011; 3(11): 367-373 [PMID: 22125672 DOI: 10.4330/wjc.v3.i11.367]
URL: https://www.wjgnet.com/1949-8462/full/v3/i11/367.htm
Number Citing Articles
1
Gregory Y.H. Lip, Stephan Windecker, Kurt Huber, Paulus Kirchhof, Francisco Marin, Jurriën M. Ten Berg, Karl Georg Haeusler, Giuseppe Boriani, Davide Capodanno, Martine Gilard, Uwe Zeymer, Deirdre Lane, Robert F. Storey, Hector Bueno, Jean-Philippe Collet, Laurent Fauchier, Sigrun Halvorsen, Maddalena Lettino, Joao Morais, Christian Mueller, Tatjana S. Potpara, Lars Hvilsted Rasmussen, Andrea Rubboli, Juan Tamargo, Marco Valgimigli, Jose L. Zamorano. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)European Heart Journal 2014; 35(45): 3155 doi: 10.1093/eurheartj/ehu298